欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号UK/V/0109/000
药品名称Advantage 100 for Dogs
活性成分
    • [No Active-Substance specified] 0.0 -
剂型Cutaneous solution
上市许可持有人Bayer AG Business Group Animal Health 51368 Leverkusen
参考成员国 - 产品名称United Kingdom (GB)
互认成员国 - 产品名称
    • Germany (DE)
      Advantage 100 for dogs (400173)
    • Denmark (DK)
      Advantage 100 for dogs
    • Belgium (BE)
      Advantage 100 voor honden
    • Netherlands (NL)
      Advantage 100 for dogs
    • Luxembourg (LU)
      Advantage 100 for dogs
    • Austria (AT)
      Advantage 100 for dogs
    • France (FR)
      Advantage 100 for dogs
    • Spain (ES)
      Advantage 100 for dogs
    • Italy (IT)
      Advantage 100 for dogs
    • Greece (GR)
      Advantage 100 for dogs
    • Sweden (SE)
      Advantage 100 for dogs
许可日期1997/08/07
最近更新日期2011/05/03
药物ATC编码
    • QP53AX Other ectoparasiticides for topical use
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase